Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Testosterone for pain perception in chronic somatoform pain disorder
2016-000048-32Phase 2Terminated
- Sponsor
- RWTH Aachen University
- Start
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of testosterone in pain disorder and Persistent Somatoform Pain Disorder (PSPD), sponsored by RWTH Aachen University. Primary endpoint: Effect of testosterone on subjective pain threshold. Started Oct 2017; status: terminated.
02
Drugs
testosterone
03
Conditions
pain disorderPersistent Somatoform Pain Disorder (PSPD)
Beyond the preview
Go deeper on 2016-000048-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-000048-32.